. 2020 Jan 27;8:e8454. doi: 10.7717/peerj.8454

Table 1. Baseline characteristics of ICC patients with different expression of UBE2T (N = 401).

Characteristics	Low (N = 288)	High (N = 113)	P value
Age, years	53.58 ± 11.14	52.82 ± 9.83	0.688
Sex			0.618
Male	211(73.3%)	80(70.8%)
Female	77(26.7%)	33(29.2%)
AFP, ng/mL	81.69 ± 236.65	112.83 ± 286.36	0.069
CEA, ng/mL	14.17 ± 84.30	14.76 ± 94.78	0.920
CA199, ng/mL	169.47 ± 274.57	140.65 ± 221.52	0.692
TBIL, µmol/L	15.58 ± 15.57	24.66 ± 55.93	0.009
ALB, g/L	42.15 ± 4.27	41.23 ± 4.67	0.144
ALT, U/L	47.55 ± 67.75	43.06 ± 44.44	0.665
GGT, U/L	108.22 ± 129.31	155.61 ± 256.95	0.060
ALP, U/L	122.85 ± 96.98	130.06 ± 105.59	0.377
HBsAg			0.085
Positive	165(57.3%)	54(47.8%)
Negative	123(42.7%)	59(52.2%)
Tumor size, cm	6.15 ± 3.35	7.33 ± 3.56	0.002
Tumor number			0.070
Single	235(81.6%)	83(73.5%)
Multiple	53(18.4%)	30(26.5%)
Surgical margin			0.776
<1 cm	213(74.0%)	82(72.6%)
≥1 cm	75(26.0%)	31(27.4%)
Liver cirrhosis			0.795
Yes	75(26.0%)	28(24.8%)
No	213(74.0%)	85(75.2%)
MVI			0.018
Positive	53(18.4%)	33(29.2%)
Negative	235(81.6%)	80(70.8%)
TNM			0.924
I–II	241(83.7%)	95(84.1%)
III–IV	47(16.3%)	18(15.9%)

Notes.